The study by Macedo and Maciel emphasized mpox - identified in 1958 - as being outstanding internationally in 2022 due to the global outbreak of the disease. The study aimed to clarify that, in 2023, ...

The World Food Programme (WFP) warned that food insecurity had worsened in the eastern Democratic Republic of the Congo (DRC) ...

The number of cases of mpox registered in Sierra Leone since the beginning of the year has hit 3,011, with 14 dead of the ...

Kenyan Lawyer Martha Karua Deported from TanzaniaKenyan lawyer and former justice minister Martha Karua was deported from Tanzania to stop her from attending opposition leader Tundu Lissu's court ...

BACKGROUND According to the last 2023 Monkeypox (Mpox) Outbreak Global Map from the Centres for Disease Control and Prevention (CDC), more than 100 countries with no Mpox infection report cases.

cDirectorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK dDepartment of Paediatric Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Liverpool, UK eRespiratory Unit ...

We are now preparing the Phase II Clinical Trial Application for NV-387 to combat MPOX for submission to the DRC regulatory agency. There is no drug available for the treatment of MPox disease.

The National Ethics Committee found that the provided information was sufficient to justify a Phase II clinical trial, and has cleared us to file a Phase II Clinical Trial Application for the Use of ...

Morocco and Tanzania have reaffirmed their commitment to strengthen their partnership in the crucial area of sustainable energy transition. During a meeting in Rabat between Moroccan Minister Leila ...

The Company is pleased to state that it is moving forward with the Phase II Clinical Trial Application (CTA) for the evaluation of NV-387 as treatment of MPox in the Domestic Republic of Congo (DRC).

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer ...